Frontotemporal dementia: Paroxetine as a possible treatment of behavior symptoms: A randomized, controlled, open 14-month study

European Neurology

Volumn 49, Issue 1, 2003, Pages 13-19

  Moretti, Rita ^a,b   Torre, Paola ^a   Antonello, Rodolfo M ^a   Cazzato, Giuseppe ^a   Bava, Antonio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Behavior treatment; Frontal lobe degeneration; Frontal type dementia; Non Alzheimer dementia; Paroxetine

Indexed keywords

PAROXETINE; PIRACETAM;

ADULT; AGE; AGED; AGGRESSIVENESS; AGITATION; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG TOLERANCE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; MEDICAL LITERATURE; NAUSEA; PRIORITY JOURNAL; STRESS; TIME;

AGED; CAREGIVERS; COST OF ILLNESS; DEMENTIA; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAROXETINE; PIRACETAM; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR DISORDERS;

EID: 18744394906     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067021     Document Type: Article

References (38)

1. Miller BL: Pick's Disease and Frontotemporal Dementias: Clinical and Biological Overview. American Academy of Neurology, Philadelphia, 2001, 2FC.005-123-134.
2. Cummings JL: Frontotemporal dementias: An update. American Academy of Neurology, San Diego, 2000, 2FC.002-72-94.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, Ed 4. Washington, American Psychiatric Association, 1994.
4. Mendez MF, Selwood A, Mastri AR, Frey WH: Pick's disease versus Alzheimer's disease: A comparison of clinical characteristics. Neurology 1993;43:289-292.
5. The Lund and Manchester Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
6. Miller BL, Ikonte C, Ponton M, Levy M, Boone K, Darby A, Berman N, Mena I, Cummings JL: A study of the Lund-Manchester research criteria for frontotemporal dementia: Clinical and single photon emission CT correlations. Neurology 1997;48:937-942.
7. Duara R, Lopez-Alberoloa RF, Barker WW, Loewenstein DA, Zatinsky M, Eisdorfer CE, Weinberg GB: A comparison of familial and sporadic Alzheimer's disease. Neurology 1993;43:1377-1382.
8. Levy ML, Miller BL, Cummings JL, Fairbanks LA, Craig A: Alzheimer disease and frontotemporal dementias: Behavioural distinctions. Arch Neurol 1996;53:687-690.
9. Sjögren M: Clinical and physiopathological aspects of FTD (oral communication). Int Congr Alzheimer's Disease vs Other Degenerative Dementias: From Biology to Treatment, Perugia, June 2000.
10. Miller BL: Frontotemporal Dementia: Clinical and Behavioral Features. American Academy of Neurology, San Diego, 2000, 3PC.007-11-22.
11. Miller Bl, Darby A, Benson DF, Cummings JL, Miller MH: Aggressive and socially disruptive and antisocial behaviour in frontotemporal dementia. Br J Psychiatry 1997;170:150-156.
12. Edwards-Lee T, Miller BL, Benson DF, Cummings JL, Russell G, Mena I: The temporal lobe variant of frontotemporal dementia. Brain 1997;120:1027-1040.
13. Mesualm MM: Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11:592-598.
14. Kertesz A: Frontotemporal degeneration, Pick disease and corticobasal degeneration: One event or three? Arch Neurol 1997;54:1427-1429.
15. Craig A, Cummings JL, Fairbanks L, Itti L, Miller BL, Mena I: Cerebral blood flow correlates of apathy in Alzheimer's disease. Arch Neurol 1996;53:1116-1120.
16. Hoyer D, Palacios JM, Mengod G: 5-HT receptor distribution in the human brain: Autoradiographic studies; in Marsden CA, Heal DJ (eds): Central Serotonin Receptors and Psychotropic Drugs. London, Blackwell Scientific Publications, 1992, pp 100-125.
17. Wood PL, Etienne P, Lal S, Nair NPV, Finlayson MH, Gauthier S, Palo J, Haltia M, Paetau A, Bird ED: A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. J Neurol Sci 1983;62:211-217.
18. Sparks DL, Markesbery WR: Altered serotoninergic and cholinergic synaptic markers in Pick's disease. Arch Neurol 1991;48:796-799.
19. Francis PT, Holmes C, Webster MT, Stratmann GC, Procter AW, Bowen DM: Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia 1993;4:72-79.
20. Miller BL, Darby A, Swartz JR, Yener GG, Mena I: Dietary changes, compulsions and sexual behaviour in fronto-temporal degeneration. Dementia 1995;6:195-199.
21. Miller BL, Ponton M, Benson DF, Cummings JL, Mena I: Enhanced artistic creativity with temporal lobe degeneration. Lancet 1996;348:1744-1755.
22. Miller BL, Cummings JL, Boone K, Prince F, Ponton M, Cotman C: Emergence of artistic talent in frontotemporal dementia. Neurology 1998;51:978-981.
23. Cummings JL: Fronto-temporal Dementia and Alzheimer's Therapy (Oral Communication). Dementia Forum, San Petersburg, September 2000.
24. Swartz R, Miller BL, Benson DF, Booth R, Darby A, Wohl M: Behavioural phenomenology in AD, fronto-temporal dementia and late-life depression: A retrospective analysis. J Geriatr Psychiatry Neurol 1997;10:67-74.
25. Swartz R, Miller BL, Darby A, Schuman S: Frontotemporal dementia: Treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997;58:212-216.
26. Folstein M, Folstein S, McHugh P: Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
27. Manos PJ: The utility of the ten-point clock test as a screen for cognitive impairment in general hospital patients. Gen Hosp Psychiatry 1997;8:469-476.
28. Gorham DR: The Proverbs Test. Missoula, Psychological Test Specialists, 1956.
29. Stroop JR: Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
30. Cummings JL, Mega M, Gray K, et al: The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
31. Ott BR, Lafleche G, Whelihan WM, et al: Impaired awareness of deficits in Alzheimer's disease. Alzheimer Dis Assoc Disord 1996;10:68-76.
32. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA: Cornell scale for depression in dementia. Biol Psychiatry 1988;23:271-284.
33. Reisberg B, Borenstein J, Salob SP, et al: Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J Clin Psychiatry 1987;48(suppl 1):9-15.
34. Mendez MF, Perryman KM, Miller BL, Cummings JL: Behavioral differences between frontotemporal dementia and Alzheimer's disease: A comparison on the BEHAVE-AD rating scale. Int J Psychogeriatr 1998;10:155-162.
35. Greene JG, Smith R, Gardiner M, Timburg GC: Measuring behavioural disturbance of elderly demented patients in the community and its effects on relatives: A factor analytic study. Age Ageing 1982;11:121-126.
36. Bathgate D, Snowden JS, Varma A, Blackshaw A, Neary D: Behavior in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001;103:367-378.
37. Lindau M, Almkvist O, Kushi J, Boone K, Johansson SE, Wahlund LO, Cummings JL, Miller BL: First-symptoms-frontotemporal dementia versus Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:286-293.
38. 3H]5-HT uptake: Effect of administration of various antidepressant treatments. Neuropharmacology 1993;32:737-743.